If this box remains here for more than 30 seconds, click this link to try again.
Industries
Functions
Home » Products & Services » Benchmarking Reports » Marketing Management » Marketing Strategy
Download FREE Excerpt
37 Info Graphics
2 Data Graphics
21 Metrics
18 Narratives
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Buy Now
However, the breakthrough therapy encountered various challenges, most notably payer resistance to its hefty price tag and competition from upcoming biosimilars. This case study from Best Practices, LLC reviews how Soliris achieved blockbuster orphan drug status – recording net product sales worth $2.8 billion in 2016 - through Alexion’s superior patient support programs, public relations campaigns and commercial expansion strategies. The study also reviews how Alexion is preparing to counter biosimilar competition.
Study Snapshot Best Practices, LLC conducted extensive secondary research on Alexion’s Soliris to review successful strategies and tactics for achieving blockbuster status for orphan drugs.
Key Findings